AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
Targeted inhibitors of oncogenic Ras (rat sarcoma viral oncogene)-Raf signaling have shown great promise in the clinic, but resistance remains a major challenge: 30% of tumors with pathway mutations do not respond to targeted inhibitors, and of the 70% that do respond, all eventually develop resista...
Main Authors: | , , , , , , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2018-08-27T18:51:15Z.
|
Subjects: | |
Online Access: | Get fulltext |